Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMP-SMX Decolonization for Preventing Acute Exacerbations in COPD Patients Colonized With Pneumocystis Jirovecii
NCT07665359Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing TMP-SMX with Placebo (2 arms). Primary endpoint: Annualized rate of moderate or severe acute exacerbations of chronic obstructive pulmonary disease at 12 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07665359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07665359.